Soroush Mana Pharmed Company (SMpharmed) started its activity as a subsidiary of Golrang pharmaceutical investment (GPI) early 2019 with a research-production approach. Soroush Mana Pharmed operates in research and development and manufacturing of APIs along with various FDFs in the Iranian pharmaceutical industry.